Latest Insider Transactions at Spectrum Pharmaceuticals Inc (SPPI)
This section provides a real-time view of insider transactions for Spectrum Pharmaceuticals Inc (SPPI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SPECTRUM PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SPECTRUM PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2023
|
Keith M Mc Gahan Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
618,312
-100.0%
|
-
|
|
Jul 31
2023
|
Brittany Bradrick Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,380
-100.0%
|
-
|
|
Jul 31
2023
|
Juhyun Lim Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,759
-100.0%
|
-
|
|
Jul 31
2023
|
Seth H. Z. Fischer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
54,066
-100.0%
|
-
|
|
Jul 31
2023
|
Nora Brennan Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
567,828
-100.0%
|
-
|
|
Jul 31
2023
|
William Ashton Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,660
-100.0%
|
-
|
|
Jul 31
2023
|
Jeff L Vacirca Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
295,244
-100.0%
|
-
|
|
Jul 31
2023
|
Thomas J Riga Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,839,639
-100.0%
|
-
|
|
May 26
2023
|
Nora Brennan Officer |
SELL
Open market or private sale
|
Direct |
32,387
-5.4%
|
$32,387
$1.1 P/Share
|
|
Mar 15
2023
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
31,381
-6.23%
|
$0
$0.8 P/Share
|
|
Mar 15
2023
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
27,197
-12.56%
|
$0
$0.8 P/Share
|
|
Mar 14
2023
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
18,153
-3.48%
|
$0
$0.82 P/Share
|
|
Mar 14
2023
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
15,733
-6.77%
|
$0
$0.82 P/Share
|
|
Feb 23
2023
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
18,385
-2.89%
|
$0
$0.77 P/Share
|
|
Feb 22
2023
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
11,990
-1.85%
|
$0
$0.76 P/Share
|
|
Feb 22
2023
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
37,009
-0.99%
|
$0
$0.77 P/Share
|
|
Jan 31
2023
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
41,014
-5.97%
|
$0
$0.62 P/Share
|
|
Jan 31
2023
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
107,424
-5.35%
|
$0
$0.66 P/Share
|
|
Jan 30
2023
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
26,138
-3.67%
|
$0
$0.54 P/Share
|
|
Jan 30
2023
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
69,389
-3.34%
|
$0
$0.54 P/Share
|
|
Jan 03
2023
|
Keith M Mc Gahan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
222,000
+23.74%
|
-
|
|
Jan 03
2023
|
Thomas J Riga Director |
BUY
Grant, award, or other acquisition
|
Direct |
888,000
+29.95%
|
-
|
|
Jan 03
2023
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
23,929
-1.97%
|
$0
$0.38 P/Share
|
|
Jan 03
2023
|
Nora Brennan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+28.56%
|
-
|
|
Nov 30
2022
|
Jeff L Vacirca Director |
BUY
Open market or private purchase
|
Direct |
50,000
+15.61%
|
$0
$0.45 P/Share
|
|
Oct 27
2022
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+18.5%
|
$0
$0.43 P/Share
|
|
Aug 31
2022
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.35%
|
-
|
|
Aug 31
2022
|
Juhyun Lim Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+45.65%
|
-
|
|
Aug 31
2022
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+31.62%
|
-
|
|
Aug 31
2022
|
Brittany Bradrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,380
+50.0%
|
-
|
|
Aug 31
2022
|
William Ashton Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+26.98%
|
-
|
|
Jun 23
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,667
-1.02%
|
$0
$0.84 P/Share
|
|
Jun 22
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,096
-0.93%
|
$0
$0.81 P/Share
|
|
Jun 21
2022
|
Nora Brennan Officer |
SELL
Open market or private sale
|
Direct |
3,569
-0.98%
|
$0
$0.78 P/Share
|
|
Jun 21
2022
|
Nora Brennan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
334,507
+47.9%
|
-
|
|
Jun 21
2022
|
Francois Lebel Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
405,040
+38.12%
|
-
|
|
Jun 21
2022
|
Thomas J Riga Director |
BUY
Grant, award, or other acquisition
|
Direct |
405,040
+25.03%
|
-
|
|
Jun 21
2022
|
Keith M Mc Gahan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
246,085
+33.39%
|
-
|
|
Jun 21
2022
|
William Ashton Director |
SELL
Open market or private sale
|
Direct |
4,283
-9.12%
|
$0
$0.78 P/Share
|
|
Jun 21
2022
|
Dolatrai Vyas |
SELL
Open market or private sale
|
Direct |
4,283
-4.96%
|
$0
$0.78 P/Share
|
|
Jun 21
2022
|
Seth H. Z. Fischer Director |
SELL
Open market or private sale
|
Direct |
5,711
-16.42%
|
$0
$0.78 P/Share
|
|
Apr 05
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,367
-0.54%
|
$1,367
$1.41 P/Share
|
|
Apr 04
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,205
-0.47%
|
$1,205
$1.35 P/Share
|
|
Mar 25
2022
|
Juhyun Lim Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,759
+50.0%
|
-
|
|
Mar 16
2022
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,318
-4.89%
|
$0
$0.71 P/Share
|
|
Mar 16
2022
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
18,829
-3.2%
|
$0
$0.71 P/Share
|
|
Mar 16
2022
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
16,318
-6.25%
|
$0
$0.71 P/Share
|
|
Mar 16
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,105
-8.96%
|
$0
$0.71 P/Share
|
|
Mar 15
2022
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,653
-5.83%
|
$0
$0.7 P/Share
|
|
Mar 15
2022
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
20,356
-3.35%
|
$0
$0.7 P/Share
|